Tsunoda Tomoyuki, Inui Ayano, Iwasawa Kentaro, Oikawa Manari, Sogo Tsuyoshi, Komatsu Haruki, Ito Yoshinori, Fujisawa Tomoo
Department of Pediatric Hepatology and Gastroenterology, Eastern Yokohama Hospital, Kanagawa, Japan.
Department of Pediatrics, Sakura Medical Center, Toho University, Chiba, Japan.
Pediatr Int. 2017 May;59(5):551-556. doi: 10.1111/ped.13249. Epub 2017 Mar 21.
The aim of the present study was to clarify the roles of cytomegalovirus (CMV), Epstein-Barr virus (EBV), and human herpesvirus 6 (HHV-6) in immunocompetent children with acute liver dysfunction not resulting from hepatitis virus.
Sixty-eight children (median age, 3 years) hospitalized as a result of acute liver dysfunction were enrolled in this study. Hepatitis A, B, and C were excluded. The prevalence of CMV, EBV, and HHV-6 and viral DNA load in whole blood was prospectively evaluated on multiplex real-time polymerase chain reaction (PCR).
Of the 68 children with acute liver dysfunction, multiplex real-time PCR was positive in 30 (44%). CMV, EBV, and HHV-6 DNA were detected in 13 (19%), 14 (21%), and seven (10%), respectively. Serum CMV immunoglobulin (Ig)G/IgM and EBV viral capsid antigen IgG/IgM were measured in 40 (CMV DNA positive, n = 10; negative, n = 30) and 45 (EBV DNA positive, n = 14; negative, n = 31) of the 68 children, respectively. Eighteen percent (CMV, 7/40) and 9% (EBV, 4/45) were positive for both PCR and viral-specific IgM. There was no significant difference in CMV and EBV viral load between IgM-positive and -negative children with viremia.
CMV, EBV, and HHV-6 DNA were frequently detected in immunocompetent children with acute liver dysfunction, but primary CMV and EBV infection were confirmed in 10-20% of the children with acute liver dysfunction. The combination of PCR assay and serology is necessary to make a diagnosis of acute liver dysfunction due to primary CMV, EBV and/or HHV-6 infection in immunocompetent children.
本研究的目的是阐明巨细胞病毒(CMV)、爱泼斯坦-巴尔病毒(EBV)和人类疱疹病毒6型(HHV-6)在非肝炎病毒所致免疫功能正常的急性肝功能障碍儿童中的作用。
本研究纳入了68名因急性肝功能障碍住院的儿童(中位年龄3岁)。排除甲型、乙型和丙型肝炎。采用多重实时聚合酶链反应(PCR)前瞻性评估全血中CMV、EBV和HHV-6的流行率及病毒DNA载量。
68名急性肝功能障碍儿童中,多重实时PCR检测阳性者30例(44%)。CMV、EBV和HHV-6 DNA分别在13例(19%)、14例(21%)和7例(10%)中检测到。分别对68名儿童中的40例(CMV DNA阳性,n = 10;阴性,n = 30)和45例(EBV DNA阳性,n = 14;阴性,n = 31)检测血清CMV免疫球蛋白(Ig)G/IgM和EBV病毒衣壳抗原IgG/IgM。PCR和病毒特异性IgM均阳性者分别为18%(CMV,7/40)和9%(EBV,4/45)。病毒血症的IgM阳性和阴性儿童之间,CMV和EBV病毒载量无显著差异。
在免疫功能正常的急性肝功能障碍儿童中,经常检测到CMV、EBV和HHV-6 DNA,但仅10%-20%的急性肝功能障碍儿童确诊为原发性CMV和EBV感染。对于免疫功能正常的儿童,要诊断原发性CMV、EBV和/或HHV-6感染所致的急性肝功能障碍,需结合PCR检测和血清学检查。